Related Experiment Video
Updated: May 12, 2026

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
Aag DNA glycosylase promotes alkylation-induced tissue damage mediated by Parp1
Jennifer A Calvo1, Catherine A Moroski-Erkul, Annabelle Lake
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Abstract:
Alkylating agents comprise a major class of front-line cancer chemotherapeutic compounds, and while these agents effectively kill tumor cells, they also damage healthy tissues. Although base excision repair (BER) is essential in repairing DNA alkylation damage, under certain conditions, initiation of BER can be detrimental. Here we illustrate that the alkyladenine DNA glycosylase (AAG) mediates alkylation-induced tissue damage and whole-animal lethality following exposure to alkylating agents. Aag-dependent tissue damage, as observed in cerebellar granule cells, splenocytes, thymocytes, bone marrow cells, pancreatic β-cells, and retinal photoreceptor cells, was detected in wild-type mice, exacerbated in Aag transgenic mice, and completely suppressed in Aag⁻/⁻ mice. Additional genetic experiments dissected the effects of modulating both BER and Parp1 on alkylation sensitivity in mice and determined that Aag acts upstream of Parp1 in alkylation-induced tissue damage; in fact, cytotoxicity in WT and Aag transgenic mice was abrogated in the absence of Parp1. These results provide in vivo evidence that Aag-initiated BER may play a critical role in determining the side-effects of alkylating agent chemotherapies and that Parp1 plays a crucial role in Aag-mediated tissue damage.
Insights
Alkyladenine DNA glycosylase (AAG) initiates DNA repair that causes tissue damage and lethality from chemotherapy alkylating agents. Suppressing AAG or Parp1 protects against these chemotherapy side effects.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Alkylating agents are crucial chemotherapy drugs but cause significant side effects by damaging healthy tissues.
- Base excision repair (BER) is vital for DNA repair, but its initiation can be harmful under specific conditions.
Purpose of the Study:
- To investigate the role of alkyladenine DNA glycosylase (AAG) in chemotherapy-induced tissue damage and lethality.
- To determine the relationship between AAG, BER, and Parp1 in mediating the toxic effects of alkylating agents.
Main Methods:
- Utilized wild-type, Aag transgenic, and Aag knockout mice to assess AAG-dependent tissue damage.
- Examined various tissues including cerebellum, spleen, thymus, bone marrow, pancreas, and retina.
- Conducted genetic experiments involving Parp1 modulation to dissect its role in AAG-mediated damage.
Main Results:
- AAG mediates alkylation-induced tissue damage and lethality across multiple cell types.
- Aag deficiency completely suppressed chemotherapy-induced tissue damage and lethality.
- Parp1 is essential for AAG-mediated tissue damage, with cytotoxicity abrogated in Parp1-deficient mice.
Conclusions:
- AAG-initiated BER plays a critical role in the detrimental side effects of alkylating agent chemotherapies.
- Parp1 is crucial in mediating AAG-induced tissue damage, highlighting a potential therapeutic target.
Related Concept Videos
Base Excision Repair
The first step of...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Overview of DNA Repair
Chemically...
Nucleotide Excision Repair
